MEC Plus Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignant Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Oral Cancer Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title Type of Media — Video Document Audio Events — 2024 California Cancer Consortium Conference (CCC) 2024 MCM 2024 MCM 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS 2024 MaTOS Lungs 2025 PRIMO Search Everything « 1 … 87 88 89 90 91 … 96 » Prostate Cancer Management from Early Biochemical Recurrence to HRPC Daniel Petrylak, MD View PDF CLL & CML (a lot on the first and not much on the second) Part 1 Javier Pinilla-Ibarz, MD, PhD View PDF CLL & CML (a lot on the first and not much on the second) Part 2 Javier Pinilla-Ibarz, MD, PhD View PDF Agnostic Tumor Drug Development Luis E. Raez, MD, FACP, FCCP View PDF Metastatic Colorectal Cancer Caio Max S. Rocha Lima, MD View PDF Myeloma Treatment: Non-transplant and Transplant Options Marco Ruiz, MD, MPH, FACP, FIDSA View PDF Integrative Survivorship in Cancer Care Maray Salina, MSN, APRN, FNP-BC View PDF EGFR & ALK: Where are We Now? Jacob Sands, MD View PDF Hypermetabolic Syndrome and Cancer Orlando E. Silva, MD View PDF CAR-T Cells: Learning How to Deal with Complications Jessica Unzaga, PharmD, BCPS, BCOP View PDF ER-PR & CDK Pathways in the Management of ER+ Metastatic Breast Cancer Vicente Valero, MD, FACP View PDF Anti-HER2 Therapies in Breast Cancer: Adjuvant and Neoadjuvant Michel Velez, MD View PDF Brain Tumors Eric T. Wong, MD View PDF Neuroendocrine Tumors of the Lung "A Spectrum of Clinical Challenges" Antoinette J. Wozniak, MD, FACP, FASCO View PDF Immunotherapy in Colorectal Cancer & MSI-High Solid Cancers Ahmed Zakari, MD View PDF The Role of Stereotactic Body Radiation Therapy (SBRT) in Lung Cancer Arya Amini, MD View PDF Therapeutic Strategies Targeting HER2 (ERBB2) Scott Christensen, MD View PDF Neoadjuvant Treatment in Thoracic Surgery Jae Kim, MD View PDF Uncommon Oncogenic Drivers in NSCLC Marianna Koczywas, MD View PDF An Introduction to Palliative Care Mayra A. Lima, ARNP, MSN, FNP-C View PDF Targeted and Immune Therapies in Lung Cancer Ravi Salgia, MD, PhD View PDF Optimizing Endocrine Therapy in ER positive, Metastatic Breast Cancer Daphne B. Stewart, MD, MS View PDF Current Issues in Checkpoint Immunotherapy for NSCLC David R. Gandara, MD View PDF Adjuvant Radiotherapy for Breast Cancer Kathleen Horst, MD View PDF Estrogen Receptor Positive Breast Cancer The Interplay Between Biology and the Logic of Treatment Suleiman A. Massarweh, MD View PDF Therapeutic Strategies Targeting ERBB2 pt 1 Mark Pegram, MD View PDF Therapeutic Strategies Targeting ERBB2 pt 2 Mark Pegram, MD View PDF Evolving Treatment Options in EGFR-mutant NSCLC Jonathan W. Riess, MD, MS View PDF Oncogene-Driven NSCLC Matthew Gubens MD View PDF Immune-Related Adverse Events (irAE) Checkpoint Inhibitors Helen Shih, NP, MPH View PDF
